Latest / Calgary News Today | 2 Min News | The Daily News Now!
GCAR1 Therapy Extends Hope for Cancer Patients | Calgary News
Scientists at the University of Calgary are pioneering a groundbreaking immunotherapy called GCAR1, re-engineering patients’ own T-cells to target and destroy solid tumors when traditional treatments fail. Early clinical results show promise: one patient lived 18 months longer, another saw tumors shrink after just a few treatments. Though still in early stages, this personalized approach could revolutionize cancer care—potentially expanding to other cancers over the next decade. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.